The role of computed tomography in the management of ovarian tumours of borderline malignancy

Brain and Language

Volumn 52, Issue 4, 1997, Pages 280-283

  Dobson, M ^a   Carrington, B M ^a   Radford, J A ^a   Buckley, C H ^b   Crowther, D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; ONCOLOGY; OVARY TUMOR; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 23744477112     PISSN: 0093934X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9260(97)80054-2     Document Type: Article

References (17)

1. Taylor HC Jr. Malignant and semi-malignant tumours of the ovary. Surgical Gynaecology and Obstetrics 1929;48:204.
2. Morrow CP. Malignant and borderline epithelial tumours of the ovary: clinical features, staging, diagnosis, intraoperative assessment and review of management In: Coppleson M, ed. Gynaecologic Oncology, 2nd ed. Edingburgh: Churchill Livingstone, 1992:889-915.
3. Bostwick DG, Tazelaar HD, Ballon SC et al. Ovarian epithelial tumours of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 1986;58:2052-2064.
4. Hart WR. Pathology of malignant and borderline ovarian tumours. In: Coppleson M ed, Gynaecologic Oncology, 2nd ed. Edingburgh: Churchill Livingstone, 1992:863-887.
5. Fox H, Buckley CH. Ovarian Neoplasms. In: Pathology for Gynaecologists, 2nd ed. London: Edward Arnold (Hodder and Stoughton), 1991:179-181.
6. Katzenstein AL, Mazur MT, Morgan TE et al. Proliferative serous tumours of the ovary. Histologic features and prognosis. American Journal of Surgical Pathology 1978;2:339-351.
7. Russell P, Merkur H. Proliferating epithelial tumours: A clinicopathological analysis of 144 cases. Australian and New Zealand Journal of Obstetrics and Gynaecology 1979;19:45-51.
8. Goldman TL, Chalas E, Chumas J. Management of borderline tumours of the ovary. Southern Medical Journal 1993;4:423-425.
9. Barnhill DR, Kurman RJ, Brady MF et al. Preliminary analysis of the behaviour of stage 1 ovarian serous tumours of low malignant potential: A gynaecologic oncologic group study. Journal of Clinical Oncology 1995;13:2752-2756.
10. Julian CG, Woodruff JD. The biologic behaviour of low-grade papillary serous carcinoma of the ovary. Obstetrics and Gynaecology 1972;40:860-867.
11. Kliman L, Rome R, Fortune DW. Low malignant potential tumours of the ovary. A study of 76 cases. Obstetrics and Gynaecology 1986;68:338-344.
12. Hart WR, Usar MC, Norris HJ. Borderline and malignant mucinous tumours of the ovary. Histologic behaviour and clinical behaviour. Cancer 1973;31:1031-1034.
13. Johnson RJ. Review: Radiology in the management of ovarian cancer. Clinical Radiology 1993;48:75-82.
14. Stevens SK, Hricak H, Stern JL et al. Ovarian lesions: detection and characterisation with gadolinium enhanced MR imaging at 1.5T. Radiology 1991;181:481-488.
15. Creasman WT, Park R, Norris H. Stage 1 borderline tumours. Obstetrics and Gynaecology 1982;59:93-95.
16. Barakat RR, Benjamin I, Lewis JL Jr. et al. Platinum based chemotherapy for advanced stage ovarian serous carcinoma of low malignant potential. Gynaecologic Oncology 1995;59:390-393.
17. Reuter KL, Griffin T, Hunter RE. Comparison of abdominopelvic computed tomography results and findings at second-look laparotomy in ovarian cancer patients. Cancer 1989;63:1123-1128.